Granules

Drug makers Lupin and Granules India have decided to recall close to 9.71 lakh bottles of generic diabetes drug in the US. They were forced to take this extreme step…

View Post

Latest News

Granules India Gets Tentative Nod From USFDA

February 13, 2020 21:00
Healthwire Bureau

New Delhi: Granules India on Thursday said the US health regulator has given its tentative approval to Guaifenesin extended-release tablets used as expectorant. “US Food & Drug Administration (USFDA) has…

View Post

Menu

Granules

Lupin, Granules India Recall 9.71 Lakh Bottles Of Diabetes Drug In The US Market

Granules India Gets Tentative Nod From USFDA

Indian Scientists Develop Method to Decode Monkeypox Virus, Enhancing Diagnostic Precision

Methanol Poisoning: All You Need to Know About The Silent Killer Lurking in Alcoholic Drinks

Winter Heart Attack Alert: 8 Doctor-Approved Lifestyle Changes for Better Cardiovascular Health

Sea Level Set to Rise 1 Metre by 2100, Threatening 14 Million in Coastal Regions: Study Warns

Not Just Smog, Surge in ‘Walking Pneumonia’ Cases Alarms Delhi Residents

Man Declared Dead In Rajasthan Hospital Found Alive Before Last Rites; 4 Doctors Suspended

Breathlessness and Persistent Coughing: Early Signs of a Progressive Lung Disease, Experts Warn

Walking Pneumonia Symptoms: The Silent Respiratory Illness You Could Be Overlooking